Verano (VRNOF) Stock Price, News & Analysis

Company Overview

Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.

Key Stats

• Today's Range: $1.17 to $1.30
• 50-Day Range: $1.12 to $1.92
• 52-Week Range: $1.11 to $7.08
• Volume: 329,182 shs
• Average Volume: 406,507 shs
• Market Capitalization: $432.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.00
• Consensus Rating: Strong Buy

Verano Stock Analysis - MarketRank™

Verano scored higher than 62% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Verano has received a consensus rating of Strong Buy. The company's average rating score is 3.67, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Verano has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Verano are expected to grow in the coming year, from ($0.18) to ($0.13) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Verano is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Verano is -2.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Verano has a P/B Ratio of 0.33. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.18% of the outstanding shares of Verano have been sold short.

Short Interest Ratio / Days to Cover

Verano has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Verano has recently increased by 2.93%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Verano does not currently pay a dividend.

Dividend Growth

Verano does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.18% of the outstanding shares of Verano have been sold short.

Short Interest Ratio / Days to Cover

Verano has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Verano has recently increased by 2.93%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: N/A

News Sentiment

Verano has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Verano this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for VRNOF on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added Verano to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Verano insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.40% of the stock of Verano is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 8.98% of the stock of Verano is held by institutions.

VRNOF Stock Analysis - Frequently Asked Questions

How have VRNOF shares performed this year?

Verano's stock was trading at $1.2450 at the beginning of 2025. Since then, VRNOF shares have decreased by 3.2% and is now trading at $1.2050.
View the best growth stocks for 2025 here.

How were Verano's earnings last quarter?

Verano Holdings Corp. (OTCMKTS:VRNOF) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.09. The company earned $216.68 million during the quarter, compared to analysts' expectations of $226.64 million. Verano had a negative net margin of 16.31% and a negative trailing twelve-month return on equity of 7.48%.

How do I buy shares of Verano?

Shares of VRNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 11/07/2024
• Today: 1/22/2025
• Next Earnings (Estimated): 2/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Agricultural production - crops
• Sub-Industry: Agriculture
• Current Symbol: OTCMKTS:VRNOF
• CUSIP: N/A
• CIK: 1848416
• Web: www.verano.com
• Phone: 312-265-0730
• Fax: N/A
• Employees: 3,900
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $7.00
• High Stock Price Target: $7.00
• Low Stock Price Target: $7.00
• Potential Upside/Downside: +480.9%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.41)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-117,350,000.00
• Net Margins: -16.31%
• Pretax Margin: 1.03%
• Return on Equity: -7.48%
• Return on Assets: -4.03%

Debt

• Debt-to-Equity Ratio: 0.39
• Current Ratio: 0.99
• Quick Ratio: 0.52

Sales & Book Value

• Annual Sales: $938.45 million
• Price / Sales: 0.46
• Cash Flow: $0.17 per share
• Price / Cash Flow: 7.14
• Book Value: $3.61 per share
• Price / Book: 0.33

Miscellaneous

• Outstanding Shares: 358,950,000
• Free Float: 319,805,000
• Market Cap: $432.53 million
• Optionable: Not Optionable
• Beta: 0.89